相关实验视频
Updated: Jul 26, 2025

08:04
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
Published on: December 20, 2017
7.0K
一项全面的免疫信息学研究,以探索和表征潜在的疫苗构造,以对抗Olea europaea的Ole e 9过敏原
Mohd Adnan Kausar1, Tulika Bhardwaj2, Fahaad Alenazi3
1Department of Biochemistry, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.
Journal of biomolecular structure & dynamics
|June 21, 2023
概括
这项研究使用计算方法探索了沙特阿拉伯橄油9 (Ole e 9) 的过敏原潜力. 这些发现支持在过敏研究中进一步调查新型候选疫苗.
科学领域:
- 免疫信息学和过敏研究
- 结构生物学和计算疫苗学
背景情况:
- 免疫球蛋白E (IgE) 介导的过敏影响超过30%的人口,由最小的过敏原暴露引发.
- 欧罗巴 (Olea europaea) 过敏原 (Ole e 9) 是一种重要的过敏原,特别适用于沙特阿拉伯的人口.
- 了解过敏原结构和IgE相互作用对于开发有针对性的过敏治疗至关重要.
研究的目的:
- 通过计算来描述Ole e 9的过敏原潜力.
- 为了确定Ole e 9内的潜在的表位和IgE结合部位.
- 使用in silico方法评估针对Ole e 9的新型疫苗构造.
主要方法:
- 系统的计算方法,包括表征预测算法.
- 过敏原的生理化学表征和二次结构分析.
- 分子对接和分子动力学模拟以评估疫苗结构稳定性和结合效率.
主要成果:
- 在Ole e 9中识别潜在的过敏原表位和IgE结合区域.
- 结构分析揭示了过敏原的关键形状和活性部位.
- 拟议的疫苗结构显示出强大而稳定的相互作用,表明具有高结合效率.
结论:
- 免疫信息学分析表明,开发的候选疫苗是安全的和免疫的.
- 这些发现支持推进这种候选疫苗进行进一步的体外和体内研究.
- 这项研究为开发沙特阿拉伯对Ole e 9过敏的有效策略提供了基础.
更多相关视频
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.5K
07:05In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
Published on: November 28, 2017
9.9K
相关概念视频
Cross-reactivity
31.3K
Overview
31.3K
Antigens Involved in Adaptive Immunity
564
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
564
Development of Immunocompetence
366
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
366